Aetna Inc. (AET) Now Covered by Analysts at Credit Suisse Group AG
Equities research analysts at Credit Suisse Group AG started coverage on shares of Aetna Inc. (NYSE:AET) in a research report issued to clients and investors on Thursday. The brokerage set a “neutral” rating and a $174.00 price target on the stock. Credit Suisse Group AG’s price target would suggest a potential upside of 2.33% from the company’s current price.
AET has been the topic of several other research reports. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $174.00 price target on the stock in a research note on Thursday, October 12th. Jefferies Group LLC reiterated a “hold” rating and issued a $163.00 price target (up previously from $157.00) on shares of Aetna in a research note on Friday, August 4th. Deutsche Bank AG boosted their price target on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. BMO Capital Markets initiated coverage on Aetna in a research note on Monday, October 16th. They issued a “market perform” rating and a $175.00 price target on the stock. Finally, Royal Bank Of Canada boosted their price target on Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research note on Friday, August 4th. Eleven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Aetna has an average rating of “Buy” and an average target price of $166.09.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The business had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. During the same quarter in the previous year, the firm posted $2.07 earnings per share. The company’s revenue was down 5.0% compared to the same quarter last year.
COPYRIGHT VIOLATION NOTICE: “Aetna Inc. (AET) Now Covered by Analysts at Credit Suisse Group AG” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/11/02/aetna-inc-aet-now-covered-by-analysts-at-credit-suisse-group-ag.html.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the sale, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.
Several institutional investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD grew its holdings in Aetna by 0.8% in the 3rd quarter. Price T Rowe Associates Inc. MD now owns 32,706,081 shares of the company’s stock worth $3,775,917,000 after buying an additional 267,743 shares in the last quarter. BlackRock Inc. grew its holdings in Aetna by 3,374.9% in the 1st quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after buying an additional 29,828,390 shares in the last quarter. Vanguard Group Inc. grew its holdings in Aetna by 3.8% in the 1st quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after buying an additional 838,578 shares in the last quarter. State Street Corp grew its holdings in Aetna by 1.5% in the 4th quarter. State Street Corp now owns 21,626,000 shares of the company’s stock worth $2,681,846,000 after buying an additional 313,689 shares in the last quarter. Finally, Capital World Investors grew its holdings in Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after buying an additional 1,688,767 shares in the last quarter. Institutional investors and hedge funds own 89.45% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.